Bausch Health Companies I... (BHC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
7.47
0.07 (0.95%)
At close: Jan 14, 2025, 3:59 PM
7.57
1.34%
Pre-market Jan 15, 2025, 08:47 AM EST
Bausch Health Companies Inc. Revenue Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Branded and Other Generic Products Revenue | 245.00M | 258.00M | 245.00M | 697.00M | 263.00M | 306.00M | 316.00M | 305.00M | 293.00M | 317.00M | 307.00M | 282.00M | 281.00M |
Branded and Other Generic Products Revenue Growth | -5.04% | +5.31% | -64.85% | +165.02% | -14.05% | -3.16% | +3.61% | +4.10% | -7.57% | +3.26% | +8.87% | +0.36% | n/a |
Device Products Revenue | 567.00M | 547.00M | 512.00M | 1.50B | 494.00M | 392.00M | 421.00M | 432.00M | 404.00M | 433.00M | 394.00M | 421.00M | 392.00M |
Device Products Revenue Growth | +3.66% | +6.84% | -65.93% | +204.25% | +26.02% | -6.89% | -2.55% | +6.93% | -6.70% | +9.90% | -6.41% | +7.40% | n/a |
Other Revenues Revenue | 28.00M | 23.00M | 24.00M | 69.00M | 25.00M | 26.00M | 371.00M | 367.00M | 324.00M | 366.00M | 352.00M | 368.00M | 326.00M |
Other Revenues Revenue Growth | +21.74% | -4.17% | -65.22% | +176.00% | -3.85% | -92.99% | +1.09% | +13.27% | -11.48% | +3.98% | -4.35% | +12.88% | n/a |
Over the Counter Products Revenue | 472.00M | 490.00M | 437.00M | 1.34B | 457.00M | 351.00M | 1.07B | 1.02B | 968.00M | 982.00M | 1.05B | 1.03B | 966.00M |
Over the Counter Products Revenue Growth | -3.67% | +12.13% | -67.39% | +193.22% | +30.20% | -67.26% | +5.30% | +5.17% | -1.43% | -6.92% | +2.53% | +6.52% | n/a |
Pharmaceutical Products Revenue | 1.20B | 1.08B | 935.00M | 2.91B | 999.00M | 937.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmaceutical Products Revenue Growth | +10.41% | +16.04% | -67.87% | +191.29% | +6.62% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2012 | Dec 31, 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Canada Revenue | 366.00M | 351.00M | 343.00M | 331.00M | 339.00M | 319.00M | 326.00M | 320.00M | 333.60M | 375.10M | 349.14M | 256.82M |
Canada Revenue Growth | +4.27% | +2.33% | +3.63% | -2.36% | +6.27% | -2.15% | +1.88% | -4.08% | -11.06% | +7.44% | +35.95% | n/a |
China Revenue | 441.00M | 413.00M | 490.00M | 341.00M | 368.00M | 361.00M | 331.00M | 300.00M | 271.50M | 232.00M | 167.44M | 151.95M |
China Revenue Growth | +6.78% | -15.71% | +43.70% | -7.34% | +1.94% | +9.06% | +10.33% | +10.50% | +17.03% | +38.55% | +10.20% | n/a |
France Revenue | 214.00M | 203.00M | 208.00M | 179.00M | 201.00M | 205.00M | 188.00M | 186.00M | 178.30M | 204.70M | 199.28M | 179.50M |
France Revenue Growth | +5.42% | -2.40% | +16.20% | -10.95% | -1.95% | +9.04% | +1.08% | +4.32% | -12.90% | +2.72% | +11.02% | n/a |
Germany Revenue | 152.00M | 147.00M | 154.00M | 144.00M | 150.00M | 170.00M | 157.00M | 157.00M | 159.40M | 204.40M | n/a | n/a |
Germany Revenue Growth | +3.40% | -4.55% | +6.94% | -4.00% | -11.76% | +8.28% | n/a | -1.51% | -22.02% | n/a | n/a | n/a |
Italy Revenue | 86.00M | 76.00M | 80.00M | 226.00M | 85.00M | 85.00M | 223.00M | 232.00M | 206.40M | 98.00M | n/a | n/a |
Italy Revenue Growth | +13.16% | -5.00% | -64.60% | +165.88% | n/a | -61.88% | -3.88% | +12.40% | +110.61% | n/a | n/a | n/a |
Japan Revenue | 194.00M | 200.00M | 230.00M | 225.00M | 241.00M | 226.00M | 201.00M | 189.00M | 203.90M | 248.70M | n/a | n/a |
Japan Revenue Growth | -3.00% | -13.04% | +2.22% | -6.64% | +6.64% | +12.44% | +6.35% | -7.31% | -18.01% | n/a | n/a | n/a |
Korea, Republic Of Revenue | 93.00M | 77.00M | 256.00M | 1.01B | 228.00M | 211.00M | 1.17B | 1.16B | 1.25B | 221.60M | n/a | n/a |
Korea, Republic Of Revenue Growth | +20.78% | -69.92% | -74.60% | +342.11% | +8.06% | -81.92% | +0.86% | -7.47% | +464.26% | n/a | n/a | n/a |
Mexico Revenue | 322.00M | 276.00M | 986.00M | 238.00M | 995.00M | 1.04B | 201.00M | 140.00M | 213.50M | 1.18B | n/a | n/a |
Mexico Revenue Growth | +16.67% | -72.01% | +314.29% | -76.08% | -4.51% | +418.41% | +43.57% | -34.43% | -81.96% | n/a | n/a | n/a |
Other Countries Revenue | 1.01B | 887.00M | 280.00M | 78.00M | 231.00M | 218.00M | 5.22B | 6.25B | 7.06B | 276.20M | n/a | n/a |
Other Countries Revenue Growth | +13.98% | +216.79% | +258.97% | -66.23% | +5.96% | -95.83% | -16.36% | -11.55% | +2457.20% | n/a | n/a | n/a |
Poland Revenue | 319.00M | 278.00M | 88.00M | 4.79B | 86.00M | 83.00M | n/a | n/a | n/a | 4.47B | n/a | n/a |
Poland Revenue Growth | +14.75% | +215.91% | -98.16% | +5470.93% | +3.61% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Spain Revenue | 92.00M | 84.00M | 4.89B | n/a | 5.16B | 5.01B | n/a | n/a | n/a | n/a | n/a | n/a |
Spain Revenue Growth | +9.52% | -98.28% | n/a | n/a | +3.05% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
United States And Puerto Rico Revenue | 5.19B | 4.84B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
United States And Puerto Rico Revenue Growth | +7.40% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 850.00M | 831.83M | 790.45M | 766.00M | 715.00M | 711.00M | 725.00M | 666.00M | 661.00M | 676.00M | 622.00M | 680.00M | 653.00M | 685.00M | 606.00M | 636.00M | 572.00M | 526.00M | 633.00M | 668.00M | 648.00M | 651.00M | 587.00M | 626.00M | 614.00M | 642.00M | 591.00M | 639.00M | 623.00M | 659.00M | 661.00M | 665.00M | 660.90M | 671.50M | 812.60M | 725.80M | 697.60M | 685.50M | 573.80M |
Selling, General, and Administrative Revenue Growth | +2.18% | +5.23% | +3.19% | +7.13% | +0.56% | -1.93% | +8.86% | +0.76% | -2.22% | +8.68% | -8.53% | +4.13% | -4.67% | +13.04% | -4.72% | +11.19% | +8.75% | -16.90% | -5.24% | +3.09% | -0.46% | +10.90% | -6.23% | +1.95% | -4.36% | +8.63% | -7.51% | +2.57% | -5.46% | -0.30% | -0.60% | +0.62% | -1.58% | -17.36% | +11.96% | +4.04% | +1.77% | +19.47% | n/a |
Research and Development Revenue | 161.00M | 155.97M | 150.33M | 152.00M | 153.00M | 156.00M | 143.00M | 142.00M | 133.00M | 127.00M | 127.00M | 117.00M | 121.00M | 115.00M | 112.00M | 119.00M | 103.00M | 108.00M | 122.00M | 114.00M | 123.00M | 117.00M | 118.00M | 120.00M | 107.00M | 94.00M | 93.00M | 90.00M | 81.00M | 95.00M | 100.00M | 93.00M | 100.80M | 124.30M | 103.10M | 236.20M | 197.40M | 93.40M | 55.80M |
Research and Development Revenue Growth | +3.23% | +3.75% | -1.10% | -0.65% | -1.92% | +9.09% | +0.70% | +6.77% | +4.72% | n/a | +8.55% | -3.31% | +5.22% | +2.68% | -5.88% | +15.53% | -4.63% | -11.48% | +7.02% | -7.32% | +5.13% | -0.85% | -1.67% | +12.15% | +13.83% | +1.08% | +3.33% | +11.11% | -14.74% | -5.00% | +7.53% | -7.74% | -18.91% | +20.56% | -56.35% | +19.66% | +111.35% | +67.38% | n/a |